TrialAmerican journal of clinical dermatology2026

Updated Integrated Safety Analysis of Ritlecitinib up to ~ 5 Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.

Maryanne Senna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.